Skip to main content
Erschienen in: Reactions Weekly 1/2014

01.10.2014 | Case report

Levetiracetam/sodium-valproate/vigabatrin

DRESS syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Rener-Primec Z, et al. Valproate-related erythrodermia with reversible encephalopathy: A rare but serious adverse reaction, case report. Acta Dermatovenerologica Alpina, Pannonica et Adriatica 23: 35-37, No. 2, 2014. Available from: URL: http://doi.org/10.15570/actaapa.2014.9 - Slovenia Rener-Primec Z, et al. Valproate-related erythrodermia with reversible encephalopathy: A rare but serious adverse reaction, case report. Acta Dermatovenerologica Alpina, Pannonica et Adriatica 23: 35-37, No. 2, 2014. Available from: URL: http://​doi.​org/​10.​15570/​actaapa.​2014.​9 - Slovenia
Metadaten
Titel
Levetiracetam/sodium-valproate/vigabatrin
DRESS syndrome: case report
Publikationsdatum
01.10.2014
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2014
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-014-4258-z

Weitere Artikel der Ausgabe 1/2014

Reactions Weekly 1/2014 Zur Ausgabe

Case report

Iomeprol

Case report

Phencyclidine

Case report

Bevacizumab

Case report

Bendamustine